|
|
Grown Rogue International Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/28/2026 15:42
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization152.46 mln
Float175 mln
Earnings Date11/18/2026
Relative Strength
80
/ 100
Strongly outperforming
Pre-Tax Margin
-4%
Marginally loss-making
Key Fundamentals
EPS-0.02
ROE-23.40
RPS0.23
ROIC7.20
ROA-7.93
Interest Cover1.92
EBITDA, mln5.30
EV / EBITDA35.56
EV / EBIT525
Revenue, mln52.24
EV / Revenue3.61
Quote Details
Last
0.65
Change
0.02 (3.17%)
Open
0.60
Volume
64,600
Turnover
41,990
Average Volume
27,246
Financial Ratios
Pre-Tax Profit Margin-4
Leverage Ratio4.25
Current Ratio2.59
Price / Book7.33
Price / Tangible Book9.00
Price / Cash Flow13.16
Debt / Equity1.79
Price / Sales3.04
Financial Strength
Altman Z-Score1.41
Piotroski F-Score
4
/ 9
Beneish M-Score-3.88
Price to Intrinsic Value15.75
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
10.17% |
86
/ 100
 |
| 1 Month |
3.17% |
69
/ 100
 |
| 2 Months |
8.33% |
75
/ 100
 |
| 6 Months |
68.83% |
90
/ 100
 |
| 1 Year |
8.33% |
61
/ 100
 |
|
| |
